5 years effectiveness of fingolimod in daily clinical practice: results of the non-interventional study PANGAEA

被引：0
|
作者：
Ziemssen, T. [1 ]
Albrecht, H.
Haas, J. [2 ]
Klotz, L. [3 ]
Lang, M.
Lassek, C.
Schmidt, S.
Tackenberg, B. [4 ]
Cornelissen, C. [5 ]
机构：
[1] Carl Gustav Carus Univ Hosp, Dresden, Germany
[2] Jewish Hosp Berlin, Berlin, Germany
[3] Univ Hosp Munster, Munster, Germany
[4] Univ Hosp Giessen & Marburg, Marburg, Germany
[5] Novartis Pharma GmbH, Nurnberg, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P745
引用
收藏
页码：372 / 373
页数：2
相关论文
共 50 条
  • [1] 5 years effectiveness of fingolimod in daily clinical practice: results of the non interventional study PANGAEA documenting RRMS patients treated with fingolimod in Germany
    Ziemssen, Tjalf
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Cornelissen, Christian
    NEUROLOGY, 2017, 88
  • [2] PANGAEA: 5 years effectiveness of fingolimod in daily clinical practice
    Ziemssen, Tjalf
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Cornelissen, Christian
    NEUROLOGY, 2018, 90
  • [3] PANGAEA: 5 years effectiveness of fingolimod in daily clinical practice
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 537 - 537
  • [4] 4 years PANGAEA: effectiveness update of a 5 year non-interventional study on the daily use of fingolimod in Germany
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 642 - 643
  • [5] 4 Years PANGAEA: A 5-Year Non-Interventional Study of Safety, Effectiveness and Pharmacoeconomic Data for Fingolimod Patients in Daily Clinical Practice - Effectiveness Update
    Cornelissen, Christian
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Ziemssen, Tjalf
    NEUROLOGY, 2016, 86
  • [6] 4 years PANGAEA: A 5-year non-interventional study of safety, effectiveness and pharmacoeconomic data for fingolimod patients in daily clinical practice - effectiveness update
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 417 - 417
  • [7] 4 Years Safety of Fingolimod in Real World: PANGAEA a Non-Interventional Study of Safety, Effectiveness and Pharmacoeconomic is Data for Fingolimod Patients in Daily Clinical Practice
    Ziemssen, Tjalf
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Cornelissen, Christian
    NEUROLOGY, 2016, 86
  • [8] 4 years safety of fingolimod in real world: PANGAEA, a non-interventional study of safety, effectiveness and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 416 - 416
  • [9] 5 years safety of fingolimod in real world: First results from PANGAEA, a non-interventional study of RRMS patients treated with fingolimod, on safety and adherence after 5 years of fingolimod in daily clinical practice
    Ziemssen, Tjalf
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Cornelissen, Christian
    NEUROLOGY, 2017, 88
  • [10] Young adult RRMS patients treated with fingolimod in daily clinical practice: interim results of the non-interventional study PANGAEA
    Ziemsseni, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    Ettle, B.
    Schulze-Topphoff, U.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 500 - 500
12345